Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
97 studies found for:    Migraine AND 5-ht1 receptor
Show Display Options
Rank Status Study
1 Completed Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Condition: Migraine
Interventions: Drug: Rapimelt;   Drug: [11C]AZ10419369
2 Recruiting Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography
Condition: Migraine Without Aura
Intervention: Other: PET scan with two different 5-HT receptor ligands
3 Completed
Has Results
"Completeness of Response" Following Treatment With Treximet™ for Migraine
Condition: Migraine
Intervention: Drug: sumatriptan succinate 85 mg/naproxen sodium 500 mg (Treximet)
4 Unknown  Treximet in Acute Migraine Headache: Assessing Cognitive Function
Conditions: Migraine Headache;   Cognitive Impairment
Interventions: Drug: Treximet;   Drug: Migraine rescue medication of choice
5 Completed Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache
Condition: Migraine
Intervention: Drug: sumatriptan and Treximet
6 Completed Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
Condition: Migraine Disorders
Interventions: Drug: Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap);   Drug: Triptan monotherapy
7 Recruiting Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: sumatriptan with naprosyn;   Drug: placebo
8 Completed Efficacy and Safety of BGG492 in the Treatment of Migraine
Condition: Migraine
Interventions: Drug: BGG492;   Drug: Sumatriptan;   Drug: Placebo
9 Completed Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
Condition: Migraine Disorders
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
10 Completed Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
Conditions: Migraine Disorders;   Migraine
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
11 Completed Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
Condition: Migraine
Interventions: Drug: Treximet;   Drug: Imitrex and two Aleve
12 Completed Trial of Comprehensive Migraine Intervention
Condition: Migraine
Interventions: Drug: Naproxen;   Drug: Sumatriptan;   Behavioral: Migraine education;   Behavioral: Reenforcement of diagnosis;   Other: Typical care
13 Completed
Has Results
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
Condition: Migraine
Interventions: Drug: Sumatriptan/Naproxen Sodium;   Drug: Naproxen Sodium
14 Completed Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
Condition: Migraine Disorders
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
15 Completed
Has Results
Treximet in the Treatment of Chronic Migraine
Condition: Chronic Migraine
Interventions: Drug: Sumatriptan/Naproxen Sodium;   Drug: Naproxen Sodium
16 Completed A Study on the Usability of the Needle-Free Intraject® System in Adult Patients During Acute Migraine Attack
Condition: Migraine Headache
Intervention: Device: Intraject Sumatriptan
17 Completed
Has Results
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Condition: Migraine
Interventions: Device: Sumavel DosePro;   Drug: Sumatriptan
18 Completed A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
Condition: Migraine
Intervention: Drug: "Investigational"Auto-injector (sumatriptan succinate)
19 Completed Dose Ranging Study of a Drug for the Treatment of Acute Migraine
Condition: Migraine - Acute
Interventions: Drug: Placebo matching BMS-927711;   Drug: BMS-927711;   Drug: Sumatriptan
20 Completed Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
Conditions: Acute Migraine;   Migraine Headache;   Headache Disorders
Interventions: Drug: Zolmitriptan 5 mg Nasal Spray;   Drug: Eletriptan 40 mg tablet

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.